Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
25.34
+0.86 (3.51%)
At close: May 29, 2026, 4:00 PM EDT
25.98
+0.64 (2.53%)
After-hours: May 29, 2026, 7:09 PM EDT
Arcus Biosciences Market Cap
Arcus Biosciences has a market cap or net worth of $3.19 billion as of May 29, 2026. Its market cap has increased by 252.44% in one year.
Market Cap
3.19B
Enterprise Value
2.42B
1-Year Change
252.44%
Ranking
Category
Stock Price
$25.34
Market Cap Chart
Since March 15, 2018, Arcus Biosciences's market cap has increased from $708.10M to $3.19B, an increase of 350.09%. That is a compound annual growth rate of 20.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 3.19B | 23.87% |
| Dec 31, 2025 | 2.57B | 88.83% |
| Dec 31, 2024 | 1.36B | -4.69% |
| Dec 29, 2023 | 1.43B | -4.52% |
| Dec 30, 2022 | 1.50B | -47.33% |
| Dec 31, 2021 | 2.84B | 68.68% |
| Dec 31, 2020 | 1.69B | 263.86% |
| Dec 31, 2019 | 463.20M | -3.26% |
| Dec 31, 2018 | 478.80M | -32.38% |
| Mar 15, 2018 | 708.10M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edgewise Therapeutics | 3.68B |
| Oruka Therapeutics | 3.53B |
| Denali Therapeutics | 3.34B |
| Beam Therapeutics | 3.28B |
| Dyne Therapeutics | 3.20B |
| Telix Pharmaceuticals | 3.18B |
| Tango Therapeutics | 3.18B |
| Relay Therapeutics | 3.06B |